NIAID Site Search

Analysis of public comments on the request for information (RFI) for NIAID's Strategic Framework for Tuberculosis Research

Last Reviewed: September 26, 2018

This is a draft specification for the Multistate, Multicomponent and Multicompartment Species Package for SBML Level 3 by Zhang and Meier-Schellersheim.

Last Reviewed: April 21, 2015

This report provides a summary of the findings from the NIAID Expert Panel on Botulinum Neurotoxins Therapeutics 2003.

Last Reviewed: May 23, 2003

This summary details an overview of the findings from the NIAID Expert Panel on Botulinum Neurotoxins Therapeutics.

Last Reviewed: November 20, 2002

NIH Centers for AIDS Research (CFAR) collaborations

Last Reviewed: December 10, 2024

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024

The 206 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Tuesday, January 30, 2024. Dr. Jeanne Marrazzo, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:45 a.m. and from 1

Last Reviewed: May 21, 2024